Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vaccinia human immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
humant vacciniaimmunglobulin 50 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
|
Product containing only Vaccinia human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Vaccinia human immune globulin 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Vaccinia human immune globulin 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Product containing only Vaccinia human immune globulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Product containing Vaccinia human immune globulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Administration of Vaccinia immune globulin, human |
Direct substance |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |
Intramuscular injection of Vaccinia immune globulin, human |
Direct substance |
True |
Vaccinia human immune globulin (substance) |
Inferred relationship |
Some |
1 |